The minor allele rs2295613(A), protective against systemic lupus erythematosus, makes a differential contribution to the activity of the <i>SLAMF1</i> gene promoter in T helpers and in regulatory T lymphocytes
SLAMF1 (CD150) is a receptor expressed on various hematopoietic cells and involved in the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE). This disorder is a chronic autoimmune inflammatory disease characterized by dysregulation of B lymphocytes, production of a large...
Saved in:
| Main Authors: | A. N. Uvarova, L. V. Putlyaeva, E. A. Zheremyan, E. M. Stasevich, M. M. Murashko, E. A. Bogomolova, K. V. Korneev, D. E. Demin, A. M. Schwartz, D. V. Kuprash |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2025-06-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/3241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A splice donor variant in SLAMF1 is associated with canine atopic dermatitis
by: Oliver P. Forman, et al.
Published: (2025-06-01) -
Correction: A splice donor variant in SLAMF1 is associated with canine atopic dermatitis
by: Frontiers Production Office
Published: (2025-08-01) -
SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade
by: Jan-Erik Sander, et al.
Published: (2025-08-01) -
Bioengineer mesenchymal stem cell for treatment of glioma by IL‐12 mediated microenvironment reprogramming and nCD47‐SLAMF7 mediated phagocytosis regulation of macrophages
by: Man Li, et al.
Published: (2024-12-01) -
ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING
by: Masafumi Taniwaki, et al.
Published: (2018-02-01)